Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amyotrophic lateral sclerosis

Air pollution may be linked to increased risk of motor neurone disease, our new study indicates

The scientist Stephen Hawking lived with amyotrophic lateral sclerosis (ALS), the most common type of motor neurone disease, for 55 years. He was one of the longest-surviving people with the condition.

The Conversation

Eric Dane has 'no reason' not to be cheerful

Actor Eric Dane has declared he has "no reason not to be in a good spirit" as he battles ALS (amyotrophic lateral sclerosis).

BANG Premier

Eric Dane given 10-minute standing ovation on Brilliant Minds set

Eric Dane was given a 10-minute standing ovation on the set of TV show Brilliant Minds after he filmed an "emotional" scene which showed his character dealing with ALS (amyotrophic lateral sclerosis) - the same condition the actor is battling in real life.

BANG Premier

From analysis to the latest developments in health,
read the most diverse news in one place.

Eric Dane determined to fight 'to the last breath' amid his ALS battle

Euphoria actor Eric Dane is determined to fight "to the last breath" amid his ALS (amyotrophic lateral sclerosis) battle, because he wants to see his teenage daughters get married and have grandkids one day.

BANG Premier

What's Going On With Coya Therapeutics Stock?

Shares of Coya Therapeutics Inc (NASDAQ:COYA) are trading higher Monday morning after the company provided an update regarding the development of a new treatment for Amyotrophic Lateral Sclerosis (ALS).

Benzinga

There is no known cure for ALS, but medical tourism exploits desperation for profit

Amyotrophic lateral sclerosis (ALS) is a devastating neurological disorder of unknown cause, in which motor nerve cells of the brain and spinal cord that transmit signals to muscles progressively degenerate. This weakens limbs and affects speech, swallowing and ultimately the ability to breathe, resulting in death, typically within just a…

The Conversation

Grey's Anatomy star Eric Dane diagnosed with ALS

'Grey's Anatomy' star Eric Dane has been diagnosed with amyotrophic lateral sclerosis (ALS) - also known as Lou Gehrig's disease - but he plans to continue working and hopes to return to the set of his TV show 'Euphoria' in the coming days.

BANG Premier

Read news from The Economist, FT, and more,
with one subscription

Leigh Whannell says COVID-19 experience inspired Wolf-Man

'Wolf Man' director Leigh Whannell has shared 'Wolf Man' was inspired by the "slow-motion nightmare" of him dealing with a loved one battling Amyotrophic Lateral Sclerosis (ALS) during the COVID-19 pandemic.

BANG Premier

Active Lifestyle With Moderate Exercise May Reduce Risk Of ALS In Men: Study

Maintaining an active lifestyle with moderate physical activity and fitness may reduce the risk of amyotrophic lateral sclerosis (ALS) in men, the study revealed.

Medical Daily

'Captain Marvel' actor Kenneth Mitchell dies at 49 due to ALS: Know all about the disease

Canadian actor Kenneth Mitchell has passed away at the age of 49 due to Amyotrophic Lateral Sclerosis (ALS), a nervous system disease. He played Joseph Danvers in Captain Marvel.

The Times of India

Terminally ill mum wants ‘happy memories’ with family after hand numbness turned out to be deadly disease

Charlotte Parker, 28, was diagnosed with amyotrophic lateral sclerosis (ALS) nine months after giving birth.

The Independent UK

Parkinson’s Drug Shows Promise In Delaying Symptoms Of ALS

Amyotrophic lateral sclerosis is an incurable disease that causes people to gradually lose control of their muscles.

Zenger

Hockey great Salming succumbed unusually quick to ALS, doctor says

Toronto Maple Leafs great Borje Salming, who passed away on Thursday from nervous disease amyotrophic lateral sclerosis (ALS), succumbed unusually quickly to the disease less than four months after diagnosis, his doctor told Swedish broadcaster SVT.

Reuters

Controversial ALS drug from Amylyx gets rare second FDA meeting

Amylyx Pharmaceuticals Inc.’s controversial treatment for amyotrophic lateral sclerosis won the support of a panel of U.S. regulatory advisers, putting the product on track for likely clearance.

Tribune News Service

Get all your
news in one place.

100’s of premium titles.
One news app.

The Japan News/Yomiuri

ALS patient sets up foundation for united front against disease

Ichiro Hatanaka, a former employee of the Japan External Trade Organization (JETRO), who was told he had a limited life expectancy after being diagnosed with ALS (amyotrophic lateral sclerosis), has established a foundation to support others fighting the disease.

Benzinga

Recap Of Tuesday's Biotech Catalysts - End of The Day Summary

European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis. AbbVie shares traded in a range of $150.33 to $153.56 on a day volume…

Benzinga

NeuroSense Shares Surge On Encouraging Data From Alzheimer's-Associated Biomarker Study

NeuroSense Therapeutics Ltd (NASDAQ:NRSN) has announced results from a biomarker study to evaluate the potential of CogniC, a combination drug for Alzheimer's disease (AD). Earlier this week, NeuroSense reported results from a stage III ALS Biomarker study evaluating PrimeC. Preliminary results showed that levels of disease-related biomarkers in people with ALS were unchanged, in contrast…

Benzinga

EXCLUSIVE: Pasithea Expands Its Core Therapeutic Pipeline With This Acquisition

Pasithea Therapeutics Corp (NASDAQ: KTTA) has acquired Alpha-5 integrin LLC, a privately-held preclinical-stage company developing a monoclonal antibody (mAbs) for amyotrophic lateral sclerosis (ALS) and other neuroinflammatory disorders.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Stealth Bio Shares Trading Higher On Pre-Clinical Presentation Of Neuromuscular Disease Candidate

Stealth BioTherapeutics (NASDAQ: MITO) presented Pre-Clinical clinical results of SBT-272 for patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) at the Keystone Neurodegeneration Symposium in Keystone, held June 5-9, 2022.

Benzinga

Why Stealth BioTherapeutics Shares Are Surging Today?

Stealth BioTherapeutics Corp (NASDAQ:MITO) presented new SBT-272 preclinical data demonstrating functional improvement in upper motor neurons with TDP-43 pathology. TDP-43 pathology plays a significant role in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The data were presented at the Keystone Neurodegeneration Symposium. A Phase 1 study to evaluate the safety and tolerability…

Benzinga

Amylyx Pharmaceuticals Shares Shoot Up As FDA Extends Review Of NDA For Neurodegenerative Disease Candidate

The U.S. Food and Drug Administration (FDA) has extended the review of New Drug Application (NDA) by three months, submitted by Amylyx Pharmaceuticals (NASDAQ: AMLX) for its lead drug candidate AMX0035 with regard to the treatment of patients with amyotrophic lateral sclerosis (ALS).

Benzinga

Voyager Therapeutics' TRACER Capsids Show Encouraging Action In Animal Models

Voyager Therapeutics Inc (NASDAQ:VYGR) will present new preclinical data on a family of AAV9-derived TRACER capsids demonstrating cross-species central nervous system transduction at the American Society of Gene and Cell Therapy Annual Meeting. Voyager's TRACER capsid discovery platform has identified a novel AAV9-derived capsid, VCAP-102, which demonstrated 50-fold better transduction in mice and…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medicines and Healthcare products Regulatory Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Amyotrophic lateral sclerosis

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.